Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer

Johns Hopkins researchers are pioneering the use of a “liquid biopsy” to predict which patients with advanced lung cancers are responding to immunotherapies and which patients may develop immune-related side effects several months later.

READ HERE

SEE ALL NEWS

Recent Posts

Variations In Telomere Lengthening Genes May Predispose Some People to Papillary Thyroid Cancer Proximity to a Cancer Center Contributes to Cancer Stage at Diagnosis Novel therapy reprograms immune cells Video: Face and jaw reconstruction after cancer surgery Combination Urothelial Cancer Treatment Nearly Doubles Patient Survival in International Trial Age-Related Changes in Skin May Contribute to Melanoma Metastases RNA-Based Therapy Shows Promise Against Aggressive Childhood Brain Tumors in Mice Johns Hopkins Researchers Develop Test to ID Aggressive Ovarian Cancers Early Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trial